Research Topics
| W R KimSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurementsKiran Bambha
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA
Am J Transplant 4:1798-804. 2004..Delta MELD is predictive of death only within 4 d of the event; however, part of this correlates with the dying process itself, thus limiting Delta MELD's utility in survival prediction models...
The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinomaW Ray Kim
Mayo Clinic College of Medicine, Division of Gastroenterology, Rochester, MN 55905, USA
Clin Liver Dis 9:225-34. 2005....
Motion - the available treatments for hepatitis C are cost effective: arguments against the motionW Ray Kim
Department of Medicine, Mayo Clinic and Foundation, Rochester 55905, USA
Can J Gastroenterol 16:710-5. 2002..Given these limitations, vis- -vis the expense, toxicity and yet limited effectiveness of the currently available antiviral agents, one should not blindly accept a conclusion that treatment for hepatitis C is cost effective...
Burden of liver disease in the United States: summary of a workshopW Ray Kim
Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Hepatology 36:227-42. 2002
Deaths on the liver transplant waiting list: an analysis of competing risksW Ray Kim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 43:345-51. 2006..In conclusion, the competing risk analysis method is useful in estimating the risk of death among patients awaiting liver transplantation...
The impact of competing risks on the observed rate of chronic hepatitis C progressionW Ray Kim
Mayo Clinic and Foundation Ch10, 200 First Street Southwest, Rochester, Minnesota 55905, USA
Gastroenterology 127:749-55. 2004..A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC...
Outcome of hospital care of liver disease associated with hepatitis C in the United StatesW R Kim
Outcomes Research Unit Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Hepatology 33:201-6. 2001..This study provides new estimates regarding the public health impact of HCV, for use in health policy decisions and cost-effectiveness analyses of preventive and therapeutic interventions...
Epidemiology and natural history of primary biliary cirrhosis in a US communityW R Kim
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Gastroenterology 119:1631-6. 2000..We report the incidence and prevalence of this condition in the general population. We also examined the validity of the Mayo natural history model for PBC among these unselected patients from the community...
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver diseaseW R Kim
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA
Hepatology 32:924-9. 2000..These data, combined with our previous study, demonstrate its applicability in a wide spectrum of disease severity, ranging from early, ambulatory-phase disease to decompensated cirrhosis necessitating liver transplantation...
Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidatesW R Kim
Mayo Clinic and Foundation, Rochester, MN 55905, USA
Liver Transpl 6:489-94. 2000..The abbreviated risk score is a convenient method to quickly estimate the risk score in patients with PBC. An abbreviated score of 6 may be consistent with the current minimal listing criteria in liver transplant candidates...
Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidatesW R Kim
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Liver Transpl 6:453-8. 2000..We advise that liver transplant candidates with RVsys >/=50 mm Hg undergo right heart catheterization to fully characterize pulmonary hemodynamics...
Outcome of liver transplantation for hepatitis B in the United StatesW Ray Kim
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Liver Transpl 10:968-74. 2004..In conclusion, these data underscore the effectiveness of therapeutic innovations that have occurred in the past two decades and indicate timely and widespread adoption of these measures by transplant centers nationwide...
The burden of hepatitis C in the United StatesW Ray Kim
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
Hepatology 36:S30-4. 2002..e., those with infection for 20 years or longer), suggesting a continued rise in the burden of HCV in the United States in the foreseeable future...
Quality of life before and after liver transplantation for cholestatic liver diseaseC R Gross
University of Minnesota, Minneapolis, MN, USA
Hepatology 29:356-64. 1999..The patients' QOL 1 year after LT could not be predicted by pretransplantation variables used in this study...
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilizationW R Kim
Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
Hepatology 30:395-400. 1999..While efforts must be made to improve the outcome following retransplantation, a more critical evaluation may be warranted for late retransplantation candidates...
Natural history of hepatitis B virus infection: an update for cliniciansSurakit Pungpapong
Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:967-75. 2007....
Daclizumab induction therapy in liver transplant recipients with renal insufficiencyS K Asrani
Mayo Clinic College of Medicine, Rochester, MN, USA
Aliment Pharmacol Ther 32:776-86. 2010..The role of interleukin 2 (IL-2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post-liver transplant (LT) period is not well defined...
Serum sodium, renal function, and survival of patients with end-stage liver diseaseYoung Suk Lim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Hepatol 52:523-8. 2010..We investigate the role of serum creatinine and sodium, and glomerular filtration rate (GFR) as determinants of survival in patients with ESLD...
Impact of MELD on waitlist outcome of retransplant candidatesH J Kim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
Am J Transplant 10:2652-7. 2010..We conclude that by and large, primary and ReTx candidates fare equitably under the current MELD-based allocation system, which has contributed to a significant increase in the probability of LTx...
The global impact of hepatic fibrosis and end-stage liver diseaseYoung Suk Lim
Division of Gastroenterology and Hepatology PL 6, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Clin Liver Dis 12:733-46, vii. 2008..Moreover, the burden of chronic liver disease is projected to increase, due in part to the increasing prevalence of end-stage liver disease and HCC secondary to NAFLD and HCV...
Trends in waiting list registration for liver transplantation for viral hepatitis in the United StatesW Ray Kim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Gastroenterology 137:1680-6. 2009....
Mortality and hospital utilization for hepatocellular carcinoma in the United StatesW Ray Kim
Division of Gastroenterology and Hepatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Gastroenterology 129:486-93. 2005..Hospital service utilization was estimated based on length of stay, total hospitalization charges, and principal procedures...
The model for end-stage liver disease (MELD)Patrick S Kamath
Advanced Liver Disease Study Group, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 45:797-805. 2007..It is possible that the addition of variables that are better determinants of liver and renal function may improve the predictive accuracy of the model. Efforts at further refinement and validation of the MELD score will continue...
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver diseaseCharmaine A Stewart
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 13:1366-71. 2007..HE may provide additional prognostic information independent of MELD, which warrants prospective validation...
Serum activity of alanine aminotransferase (ALT) as an indicator of health and diseaseW Ray Kim
Mayo Clinic College of Medicine, Rochester, MN, USA
Hepatology 47:1363-70. 2008
Hyponatremia and mortality among patients on the liver-transplant waiting listW Ray Kim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
N Engl J Med 359:1018-26. 2008..Under the current liver-transplantation policy, donor organs are offered to patients with the highest risk of death...
The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measurePatrick S Kamath
Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Clin Liver Dis 13:63-6. 2009..8, indicating excellent discrimination...
Epidemiology of hepatitis B in the United StatesW Ray Kim
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 49:S28-34. 2009....
Impact of pretransplant hyponatremia on outcome following liver transplantationByung Cheol Yun
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 49:1610-5. 2009..The incidence of CPM correlates with hyponatremia, although its overall incidence is low. Incorporation of serum sodium in organ allocation may not adversely affect the overall post-OLT outcome...
MELD accurately predicts mortality in patients with alcoholic hepatitisWinston Dunn
Advanced Liver Disease Study Group, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 41:353-8. 2005..MELD is a useful clinical tool for gauging mortality and guiding treatment decisions in patients with AH, particularly those complicated by ascites and/or encephalopathy...
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States communityKiran Bambha
Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Gastroenterology 125:1364-9. 2003..Our data suggest that the prevalence of PSC in the United States, with its attendant medical burdens, is significantly greater than previously estimated...
Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysisJayant A Talwalkar
Transplant Center, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 78:431-5. 2003..To determine the level of association between minimal listing criteria (MLC) recognition and outcomes associated with waiting list registration for liver transplantation (LT)...
Medical and economic impact of autoimmune hepatitisJayant A Talwalkar
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, S W Rochester, MN 55905, USA
Clin Liver Dis 6:649-67. 2002..As a result, the ability to plan for disease management strategies in AIH that require the allocation of scarce resources will be feasible...
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patientsWalter K Kremers
The William J von Liebig Transplant Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
Hepatology 39:764-9. 2004..68). In conclusion, liver allocation within the Status 1 designation may need to be further stratified by diagnosis, and MELD score may be useful for prioritizing FHF-NA candidates...
Changing epidemiology of hepatitis B in a U.S. communityW Ray Kim
Division of Gastroenterology and Hepatology Mayo 16E, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Hepatology 39:811-6. 2004..69) and age greater than 40 years (OR = 2.32 per decade). In conclusion, in this Midwestern community, chronic HBV infection was predominantly seen in immigrants from endemic parts of the world...
Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantationDavid J Vanness
Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905, USA
Health Econ 11:551-66. 2002..The approach allows flexibility in assessing treatment in various counterfactual premises and quantifies the global effect of parametric uncertainty on a decision-maker's confidence in adopting one therapy over the other...
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondSumeet K Asrani
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Curr Opin Gastroenterol 26:209-13. 2010..Prognostic models have been proposed to either refine or improve the current MELD-based liver allocation...
Development and maintenance of a community-based hepatitis C registryBarbara P Yawn
Department of Clinical Research, Olmsted Medical Center, Rochester, MN 55904, USA
Am J Manag Care 8:253-61. 2002..To develop a model for community-population- or health system-based registries of all patients with diagnosed hepatitis C, to facilitate clinical care and epidemiologic studies...
Increased prevalence and mortality in undiagnosed celiac diseaseAlberto Rubio-Tapia
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
Gastroenterology 137:88-93. 2009..The historical prevalence and long-term outcome of undiagnosed celiac disease (CD) are unknown. We investigated the long-term outcome of undiagnosed CD and whether the prevalence of undiagnosed CD has changed during the past 50 years...
Serum aminotransferase activity and mortality risk in a United States communityTae Hoon Lee
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA
Hepatology 47:880-7. 2008..95 for AST, 0.61 for ALT). CONCLUSION: Serum levels of AST and ALT obtained in a routine medical care setting are associated with future mortality in community residents...
Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosisK Bambha
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Gut 57:814-20. 2008..The aim of this study was to determine risk factors for 6-week mortality, and re-bleeding within 5 days in patients with cirrhosis and AVH...
Diagnosis and 10-year follow-up of a community-based hepatitis C cohortBarbara P Yawn
Department of Clinical Research, Olmsted Medical Center, 210 Ninth St, SE, Rochester, MN 55904, USA
J Fam Pract 51:135-40. 2002..To determine the health care follow-up and treatment associated with physician-diagnosed hepatitis C (HCV) in a community-based population...
Donor race does not predict graft failure after liver transplantationSumeet K Asrani
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Gastroenterology 138:2341-7. 2010..We evaluated the extent to which the center where the transplantation surgery was performed and other potential confounding factors might account for the observed association between donor race and graft failure...
Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascitesLuke T Evans
Advanced Liver Diseases Study Group, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 37:897-901. 2003..In addition, the organisms cultured from ascitic fluid in outpatients are predominantly gram positive. A reassessment of diagnostic criteria for spontaneous bacterial peritonitis in outpatients may be required...
Alcoholic liver disease-related mortality in the United States: 1980-2003Helga Paula
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Am J Gastroenterol 105:1782-7. 2010....
Risk factors for mortality after surgery in patients with cirrhosisSwee H Teh
Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, Minnesota, USA
Gastroenterology 132:1261-9. 2007..The aim of this study was to determine the risk factors for postoperative mortality in patients with cirrhosis...
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfallsKiran Bambha
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Eur J Gastroenterol Hepatol 16:519-26. 2004....
Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysisSumeet K Asrani
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 52:1360-70. 2010....
Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplantKiran Bambha
Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, Denver, USA
Mayo Clin Proc 85:814-20. 2010..To identify single nucleotide polymorphisms (SNPs) associated with risk of developing chronic kidney disease (CKD), a prevalent comorbidity, after liver transplant (LT)...
Survival after liver transplantation: Is racial disparity inevitable?Tae Hoon Lee
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN, USA
Hepatology 46:1491-7. 2007..CONCLUSION: These data demonstrate that as a proof of principle, minority OLT recipients should not necessarily expect an OLT outcome inferior to that of Caucasians...
Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis CStanley S Liu
Viral Hepatitis Study Group, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
J Clin Gastroenterol 44:e178-85. 2010..The aim of our study was to examine the influence of antidepressant treatment and whether this improves the likelihood of completing therapy...
Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treatLiliana Gazzuola Rocca
Department of Clinical Research, Olmsted Medical Center, Rochester, Minn 55904, USA
Ann Fam Med 2:116-24. 2004..In addition, generalists' recognition and treatment of potentially reversible contraindications to hepatitis C therapy could greatly increase the number of treatment candidates...
Employment and health insurance in long-term liver transplant recipientsCatherine Rongey
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Am J Transplant 5:1901-8. 2005..1), physical function score>52.4 (OR=3.6) and general health score>33.3 (OR=7.6) were significantly associated with employment. These data may help identify high-risk pre-OLT patients for intervention measures such as work rehabilitation...
Evidence-based incorporation of serum sodium concentration into MELDScott W Biggins
University of California San Francisco, San Francisco, California, USA
Gastroenterology 130:1652-60. 2006..CONCLUSIONS: We demonstrate an evidence-based method to incorporate Na into MELD, which provides more accurate survival prediction than MELD alone...
Liver transplantation is effective, but is it cost-effective?Kiran Bambha
Liver Transpl 9:1308-11. 2003
Is the change in MELD score a better indicator of mortality than baseline MELD score?Patrick S Kamath
Liver Transpl 9:19-21. 2003
Pretransplantation disease severity and posttransplantation outcomeW Ray Kim
Liver Transpl 9:124-5. 2003
Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective?W Ray Kim
Gastroenterology 134:641; author reply 641-2. 2008
Mortality attributable to cholestatic liver disease in the United StatesFlavia D Mendes
Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, FL, USA
Hepatology 47:1241-7. 2008..These changes may be attributable to liver transplantation or ursodeoxycholic acid. In contrast, mortality from PSC remained largely unchanged, highlighting the need for more effective therapeutic strategies...
Benefits of "the benefit model" in liver transplantationW Ray Kim
Hepatology 48:697-8. 2008
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?Sarwa Darwish Murad
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Liver Transpl 13:867-74. 2007..65-0.85). In conclusion, MELD showed a suboptimal discriminative ability to predict survival in BCS. This was explained by the highly variable degree of liver dysfunction and hence clinical outcome in BCS in contrast to ESLD...
A glossary of economic termsNaoki Chiba
Eur J Gastroenterol Hepatol 16:563-5. 2004
Research Grants
- Models for Optimal Liver Transplant OutcomesW Ray Kim; Fiscal Year: 2006..abstract_text> ..
- Epidemiology and Impact of Hepatitis C in the CommunityW Ray Kim; Fiscal Year: 2007..abstract_text> ..
- Models for Optimal Liver Transplant OutcomesW Ray Kim; Fiscal Year: 2007....
- Models for Optimal Liver Transplant OutcomesW Ray Kim; Fiscal Year: 2009....
- Models for Optimal Liver Transplant OutcomesW Ray Kim; Fiscal Year: 2010....
